drugset / Trial / NCT00427557

Cellular Therapy With Cord Blood Cells

NCT00427557 ↗

Phase 2 Completed 31 enrolled M.D. Anderson Cancer Center
NaSingle-groupOpen-labelTreatment

Summary

The goal of this clinical research study is to learn if giving umbilical cord blood along with standard stem cells after high-dose chemotherapy will improve the response to a stem cell transplant. The safety of this treatment will also be studied.

Timeline

Start
2006-10
Primary completion
2010-11
Completion
2010-11

Drugs

EvaluationDrugModalityDoseRoute
Background Fludarabine Small molecule 30 mg/m2 Intravenous
Background Melphalan Small molecule 140 mg/m2 Intravenous
Background Rituximab Monoclonal antibody 375 mg/m2 Intravenous